Literature DB >> 18403192

Genetically determined lymphopenia and autoimmune manifestations.

Anna Villa1, Veronica Marrella, Francesca Rucci, Luigi D Notarangelo.   

Abstract

Hypomorphic defects of V(D)J recombination in humans lead to residual T cell development. In these lymphopenic conditions, homeostatic lymphocyte proliferation occurs, and key mechanisms that normally maintain host tolerance are altered, allowing peripheral expansion of oligoclonal and autoreactive T cells. Recently described murine models support this notion. This review describes human and murine situations, in which genetically determined T and B cell lymphopenia is associated with autoimmune manifestations.

Entities:  

Mesh:

Year:  2008        PMID: 18403192     DOI: 10.1016/j.coi.2008.02.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  9 in total

1.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

Review 2.  New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression.

Authors:  Scott M Steward-Tharp; Yun-jeong Song; Richard M Siegel; John J O'Shea
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 3.  Autoimmunity and primary immunodeficiency: two sides of the same coin?

Authors:  Reinhold E Schmidt; Bodo Grimbacher; Torsten Witte
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

Review 4.  Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies.

Authors:  Jolan E Walter; Jocelyn R Farmer; Zsofia Foldvari; Troy R Torgerson; Megan A Cooper
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

Review 5.  Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.

Authors:  Liutao Du; Richard A Gatti
Journal:  J Immunol Methods       Date:  2010-12-13       Impact factor: 2.303

6.  Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

Authors:  Jocelyn R Farmer; Zsofia Foldvari; Boglarka Ujhazi; Suk See De Ravin; Karin Chen; Jack J H Bleesing; Catharina Schuetz; Waleed Al-Herz; Roshini S Abraham; Avni Y Joshi; Beatriz T Costa-Carvalho; David Buchbinder; Claire Booth; Andreas Reiff; Polly J Ferguson; Asghar Aghamohammadi; Hassan Abolhassani; Jennifer M Puck; Mehdi Adeli; Caterina Cancrini; Paolo Palma; Alice Bertaina; Franco Locatelli; Gigliola Di Matteo; Raif S Geha; Maria G Kanariou; Lilia Lycopoulou; Marianna Tzanoudaki; John W Sleasman; Suhag Parikh; Gloria Pinero; Bernard M Fischer; Ghassan Dbaibo; Ekrem Unal; Turkan Patiroglu; Musa Karakukcu; Khulood Khalifa Al-Saad; Meredith A Dilley; Sung-Yun Pai; Cullen M Dutmer; Erwin W Gelfand; Christoph B Geier; Martha M Eibl; Hermann M Wolf; Lauren A Henderson; Melissa M Hazen; Carmem Bonfim; Beata Wolska-Kuśnierz; Manish J Butte; Joseph D Hernandez; Sarah K Nicholas; Polina Stepensky; Shanmuganathan Chandrakasan; Maurizio Miano; Emma Westermann-Clark; Vera Goda; Gergely Kriván; Steven M Holland; Olajumoke Fadugba; Sarah E Henrickson; Ahmet Ozen; Elif Karakoc-Aydiner; Safa Baris; Ayca Kiykim; Robbert Bredius; Birgit Hoeger; Kaan Boztug; Olga Pashchenko; Benedicte Neven; Despina Moshous; Jean-Pierre de Villartay; Ahmed Aziz Bousfiha; Harry R Hill; Luigi D Notarangelo; Jolan E Walter
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-12

Review 7.  Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.

Authors:  Lisa S Westerberg; Christoph Klein; Scott B Snapper
Journal:  Curr Opin Immunol       Date:  2008-11-12       Impact factor: 7.486

8.  Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency.

Authors:  Jan Rohr; Ulrich Pannicke; Michaela Döring; Annette Schmitt-Graeff; Elisabeth Wiech; Andreas Busch; Carsten Speckmann; Ingo Müller; Peter Lang; Rupert Handgretinger; Paul Fisch; Klaus Schwarz; Stephan Ehl
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

Review 9.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.